Diabetes Treatments | Novo Nordisk U.S.
View a list of Novo Nordisk's current diabetes products along with prescribing information and links to their individual product sites for patients and physicians.
Our products - Novo Nordisk
Overview of Novo Nordisk pharmaceutical products within diabetes, obesity, haemophilia, human growth hormone and hormone replacement therapy.
Our medicines | Diabetes medications | Obesity medication - Novo Nordisk
Overview of our diabetes medications, obesity medication and also medicines within haemophilia, human growth hormone and hormone replacement therapy.
Diabetes Treatments & Insulin Pen Devices | NovoCare®
Find information about Novo Nordisk medications and devices used to treat diabetes, including insulin and non-insulin medicines.
Type 2 diabetes - Novo Nordisk
We are committed to driving change to improve treatment options for people living with type 2 diabetes – from more effective medicines to better delivery systems that make management simpler and more convenient.
Our products | Novo Nordisk U.S.
Novo Nordisk offers more than 20 medicines for diabetes, chronic weight management, rare bleeding disorders, hormone-related growth disorders and women’s health.
Treatment Options for Type 2 Diabetes - NovoCare
There are many medication options for treating type 2 diabetes. Learn the differences between GLP-1 RA, insulin, non-insulin, oral anti-diabetic drugs, and more.
About Type 1 and Type 2 Diabetes | Novo Nordisk U.S.
Learn about Type 1 and Type 2 diabetes and how Novo Nordisk is chasing the next breakthrough treatment.
Diabetes Treatment Options | NovoCare® Diabetes Education
Understand why medication is crucial for managing your diabetes and how it can help you control your blood sugar. Learn about insulin, GLP-1 RAs, and more.
Explore Diabetes Products - Novo Nordisk
Visit novonordisk.com for an overview of our treatment options for people living with diabetes. It’s time to reinvent the basal insulin start experience with Awiqli - the world’s first once-weekly basal insulin.